Regulation of gene expression in Leishmania

Research summary:

Protists of the Leishmania genus include species causing severe diseases in humans, i.e. leishmaniasis. Moreover, Leishmania species are the subject of fundamental interest regarding the evolution of gene regulatory mechanisms, as these organisms have put aside transcriptional regulation. There is currently no acceptable vaccine for preventing leishmaniasis and treatment options are limited. The research activity of our group is focused on studying, on the one hand, genome organization and gene expression in this parasite, and, on the other hand, the immuno-pathological outcomes associated with the infections caused by this parasite. Our aim is contributing knowledge for the development of new methods of controlling this parasitosis.

Massive sequencing techniques have become routine tools in our group for studying molecular mechanisms of gene expression in this parasite. These tasks are being done in close collaboration with Dr Begoña Aguado (head of the Genomics & Massive Sequencing service at CBMSO). Our group has generated new assemblies, improving previous ones, for the genomes of prototypical Leishmania species like L. infantum, causative agent of visceral leishmaniasis in Spain and other countries around the Mediterranean basin, and L. braziliensis, causing mucocutaneous leishmaniasis in South America. For hosting this information, which is actively curated, a web page was created: http://leish-esp.cbm.uam.es. Furthermore, we are using massive RNA sequencing (RNA-seq) for the annotation of transcriptomes of several Leishmania species and to study changes in gene expression. Thus, RNA-seq was used to determine genes involved in parasite resistance against the drugs currently available for treatment of human leishmaniasis. Additionally, we are looking for regulatory cis-elements, often found in the 3’ untranslated regions (UTRs) of mRNAs, associated with RNA-binding proteins (RBPs), as key players in the regulation of gene expression.

Another area of active research, headed by Dr Manuel Soto, is aimed to the study of Leishmania – host immune response interactions, towards the development of prophylactic tools for preventing Leishmania infection. In this regards, a genetically modified-Leishmania mutant line (LiΔHSP70-II) is being analyzed as a promising vaccine; its inoculation induces memory and effector T cell responses against Leishmania able to control subsequent challenges. Finally, as members of the Tropical Diseases network (ISCIII; http://www.ricet.es/es/), our group is engaged in collaborative research activities with different national health institutions.

Image

Regulation of gene expression in Leishmania occurs exclusively at the post-transcriptional level.

Image


* For external calls please dial 34 91196 followed by the extension number
Last nameNameLaboratoryExt.*e-mailProfessional category
Camacho CanoEsther3024647ecamacho(at)cbm.uam.esTitulado Sup.de Actividades Técn. y Profes. GP1
Miao Hui3024647Estudiante
Reinoso DueñasMauricio Alejandro3024617Estudiante TFG
Requena RolaniaJosé María3024617jmrequena(at)cbm.csic.esProfesor Titular Universidad, GA

Relevant publications:

  • Camacho, E., Gonzalez-de la Fuente, S., Rastrojo, A., Peiro-Pastor, R., Solana, J.C., Tabera, L., Gamarro, F., Carrasco-Ramiro, F., Requena, J.M., and Aguado, B. (2019). Complete assembly of the Leishmania donovani (HU3 strain) genome and transcriptome annotation. Sci Rep 9, 6127. doi: 10.1038/s41598-019-42511-4
  • Rastrojo, A., Corvo, L., Lombraña, R., Solana, J.C., Aguado, B., and Requena, J.M. (2019). Analysis by RNA-seq of transcriptomic changes elicited by heat shock in Leishmania major. Sci Rep 9, 6919. doi: 10.1038/s41598-019-43354-9
  • Camacho, E., Rastrojo, A., Sanchiz, A., Gonzalez-de la Fuente, S., Aguado, B., and Requena, J.M. (2019). Leishmania Mitochondrial Genomes: Maxicircle Structure and Heterogeneity of Minicircles. Genes (Basel) 10: 758. doi: 10.3390/genes10100758
  • Diaz, J.R., Ramirez, C.A., Nocua, P.A., Guzman, F., Requena, J.M., and Puerta, C.J. (2018). Dipeptidyl peptidase 3, a novel protease from Leishmania braziliensis. PLoS One 13, e0190618. doi: 10.1371/journal.pone.0190618
  • Rastrojo, A., Garcia-Hernandez, R., Vargas, P., Camacho, E., Corvo, L., Imamura, H., Dujardin, J.C., Castanys, S., Aguado, B., Gamarro, F., and Requena, J.M. (2018). Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs. Int J Parasitol Drugs Drug Resist 8, 246-264. doi: 10.1016/j.ijpddr.2018.04.002
  • Garde, E., Ramirez, L., Corvo, L., Solana, J.C., Martin, M.E., Gonzalez, V.M., Gomez-Nieto, C., Barral, A., Barral-Netto, M., Requena, J.M., Iborra, S., and Soto, M. (2018). Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis. Front Cell Infect Microbiol 8, 112. doi: 10.3389/fcimb.2018.00112
  • Gonzalez-de la Fuente, S., Camacho, E., Peiro-Pastor, R., Rastrojo, A., Carrasco-Ramiro, F., Aguado, B., and Requena, J.M. (2018). Complete and de novo assembly of the Leishmania braziliensis (M2904) genome. Mem Inst Oswaldo Cruz 114, e180438. doi: 10.1590/0074-02760180438
  • Requena, J.M., Rastrojo, A., Garde, E., Lopez, M.C., Thomas, M.C., and Aguado, B. (2017). Genomic cartography and proposal of nomenclature for the repeated, interspersed elements of the Leishmania major SIDER2 family and identification of SIDER2-containing transcripts. Mol Biochem Parasitol 212, 9-15. doi: 10.1016/j.molbiopara.2016.12.009
  • Solana, J.C., Ramirez, L., Corvo, L., de Oliveira, C.I., Barral-Netto, M., Requena, J.M., Iborra, S., and Soto, M. (2017). Vaccination with a Leishmania infantum HSP70-II null mutant confers long-term protective immunity against Leishmania major infection in two mice models. PLoS neglected tropical diseases 11, e0005644. doi: 10.1371/journal.pntd.0005644
  • Gonzalez-de la Fuente, S., Peiro-Pastor, R., Rastrojo, A., Moreno, J., Carrasco-Ramiro, F., Requena, J.M., and Aguado, B. (2017). Resequencing of the Leishmania infantum (strain JPCM5) genome and de novo assembly into 36 contigs. Sci Rep 7, 18050. doi: 10.1038/s41598-017-18374-y

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand

COOKIES POLICY

What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

  • Accept cookies: if the user presses the acceptance button, this warning will not be displayed again when accessing any page of the portal.
  • Review the cookies policy: the user can access to this page in which the use of cookies is detailed, as well as links to modify the browser settings.

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: